The U.S. Food and Drug Administration on Friday approved AbbVie Inc's new treatment for rheumatoid arthritis, a win for the drugmaker seeking to ...
The U.S. Food and Drug Administration on Friday approved AbbVie Inc's new treatment for rheumatoid arthritis, a win for the drugmaker seeking to widen its portfolio as its blockbuster flagship therapy Humira faces competition.
FILE PHOTO: A screen displays the share price for pharmaceutical maker AbbVie on the floor of the New York Stock Exchange July 18, 2014. REUTERS/Brendan McDermid
Singapore Latest News, Singapore Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
FDA approves Celgene's bone marrow cancer treatmentREUTERS: The U.S. Food and Drug Administration said on Friday it had approved Celgene Corp's treatment, Inrebic, for certain forms of bone marrow ...
Read more »
Roche's personalized cancer treatment wins FDA approvalThe U.S. Food and Drug Administration approved Roche Holding AG's personalized cancer treatment, the agency said on Thursday.
Read more »
US FDA proposes graphic warnings on cigarette packs, advertisementsThe U.S. Food and Drug Administration on Thursday proposed new health warnings for cigarette packages and advertisements that it said could be the ...
Read more »
FDA proposes new health warnings on cigarette packetsThe U.S. Food and Drug Administration on Thursday proposed new health warnings for cigarette packages and advertisements that it said could be the ...
Read more »
US FDA approves TB Alliance's treatment for drug-resistant tuberculosisThe U.S. Food and Drug Administration has approved TB Alliance's treatment for drug-resistant tuberculosis as part of a three-drug combination ...
Read more »
US FDA approves TB Alliance's treatment for drug-resistant tuberculosisThe U.S. Food and Drug Administration has approved TB Alliance's treatment for drug-resistant tuberculosis as part of a three-drug combination ...
Read more »